Helicos BioSciences (FRA:HB4) 12-1 Month Momentum % : N/A% (As of Jun. 22, 2024)

View and export this data going back to . Start your Free Trial

What is Helicos BioSciences 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-06-22), Helicos BioSciences's 12-1 Month Momentum % is N/A%.

The industry rank for Helicos BioSciences's 12-1 Month Momentum % or its related term are showing as below:

FRA:HB4's 12-1 Month Momentum % is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: -3.81
* Ranked among companies with meaningful 12-1 Month Momentum % only.

Competitive Comparison of Helicos BioSciences's 12-1 Month Momentum %

For the Drug Manufacturers - Specialty & Generic subindustry, Helicos BioSciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Helicos BioSciences's 12-1 Month Momentum % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Helicos BioSciences's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Helicos BioSciences's 12-1 Month Momentum % falls into.

Helicos BioSciences (FRA:HB4) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %

( Price 1-month ago

Price 12-month ago

- 1 )

100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Helicos BioSciences (FRA:HB4) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

Helicos BioSciences 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Helicos BioSciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.

Helicos BioSciences (FRA:HB4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Helicos BioSciences Corp (FRA:HB4) » Definitions » 12-1 Month Momentum %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Helicos BioSciences Corp is incorporated in the state of Delaware and was incorporated on May 9, 2003. It is a life sciences company focused on genetic analysis technologies for the research, drug discovery and clinical diagnostics markets. The Company's products are based on its proprietary True Single Molecule Sequencing (tSMS) technology which enables rapid analysis of large quantities of genetic material by directly sequencing single molecules of DNA or single DNA copies of RNA. The Company's Helicos Genetic Analysis Platform is designed to obtain sequencing information by repetitively performing a cycle of biochemical reactions on individual DNA molecules and imaging the results after each cycle. The platform consists of an instrument called the HeliScope Single Molecule Sequencer, an image analysis computer tower called the HeliScope Analysis Engine, associated reagents, which are chemicals used in the sequencing process, and disposable supplies. The Company is subject, both directly and indirectly, to the adverse impact of existing and potential future government regulation of its operations and markets.

Helicos BioSciences (FRA:HB4) Headlines

No Headlines